Page last updated: 2024-08-17

tetrabenazine and Neuroleptic Malignant Syndrome

tetrabenazine has been researched along with Neuroleptic Malignant Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, Y; Ikeda, T; Ishida, C; Kato-Motozaki, Y; Komai, K; Nozaki, I; Tagami, A; Takahashi, K1
Guay, DR1
Laterre, C; Ossemann, M; Sindic, CJ1
Bressman, SB; Petzinger, GM1
Giménez-Roldán, S; Mateo, D; Muñoz-Blanco, JL1

Reviews

1 review(s) available for tetrabenazine and Neuroleptic Malignant Syndrome

ArticleYear
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    The American journal of geriatric pharmacotherapy, 2010, Volume: 8, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Depression; Dopamine; Drug Interactions; Genotype; Humans; Huntington Disease; Hyperkinesis; Middle Aged; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Quinolizines; Reserpine; Serotonin; Tetrabenazine; Vesicular Monoamine Transport Proteins; Young Adult

2010

Other Studies

4 other study(ies) available for tetrabenazine and Neuroleptic Malignant Syndrome

ArticleYear
Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington's disease at the terminal stage of recurrent breast cancer.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged, 80 and over; Antipsychotic Agents; Breast Neoplasms; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Huntington Disease; Middle Aged; Neoplasm Recurrence, Local; Neuroleptic Malignant Syndrome; Tetrabenazine; Tiapride Hydrochloride

2014
Tetrabenazine as a cause of neuroleptic malignant syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1

    Topics: Anti-Dyskinesia Agents; Dose-Response Relationship, Drug; Humans; Huntington Disease; Long-Term Care; Male; Middle Aged; Neuroleptic Malignant Syndrome; Tetrabenazine

1996
A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:2

    Topics: Adult; Anti-Dyskinesia Agents; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Neuroleptic Malignant Syndrome; Neurologic Examination; Tetrabenazine; Thiothixene

1997
Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:1

    Topics: Female; Haloperidol; Humans; Huntington Disease; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome; Tetrabenazine

1992